cefixime has been researched along with sildenafil citrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akazawa, M; Dararath, E; Khan, MH; Kiet, HB; Kimura, K; Nivanna, N; Sovannarith, T; Tabata, H; Tanimoto, T; Tsuboi, H; Yoshida, N | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
2 other study(ies) available for cefixime and sildenafil citrate
| Article | Year |
|---|---|
A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010.
Topics: Cambodia; Cefixime; Clarithromycin; Counterfeit Drugs; Drug Labeling; Drugs, Essential; Fraud; Omeprazole; Piperazines; Public Health Surveillance; Purines; Quality Control; Sildenafil Citrate; Sulfones; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |